Spyre Therapeutics, Inc. SYRE
97.63 USD -3.83 (-3.77%)
Regular-session close
97.63 0.00 0.00%
After hours · Nov 19, 4:56 PM ET
97.49 Day range 103.50
23.01 52-week range 110.64
- YTD
- +198.02%
- 1 year
- +301.77%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 209.56M | 208.57M | 243.19M | 87.11M | 84.39M | |
| 171.65M | 162.79M | 89.50M | 58.58M | 57.07M | |
| 47.91M | 45.78M | 39.95M | 28.53M | 27.32M | |
| -209.56M | -208.57M | -242.30M | -84.78M | -65.65M | |
| -15.00K | 51.00K | -26.00K | -136.00K | 141.00K | |
| -155.20M | -208.02M | -338.79M | -83.81M | -65.80M | |
| -155.20M | -208.02M | -338.79M | -83.81M | -65.80M | |
| -155.20M | -208.02M | -338.79M | -83.81M | -65.80M | |
| -155.20M | -208.02M | -338.79M | -83.81M | -65.80M | |
| -1.98 | -3.18 | -13.76 | -24.86 | -25.02 | |
| -1.98 | -3.18 | -13.76 | -24.86 | -25.02 | |
| -1.98 | -3.18 | -13.76 | -24.86 | -25.02 | |
| -155.22M | -207.97M | -338.82M | -83.95M | -65.66M | |
| -155.22M | -207.97M | -338.82M | -83.95M | -65.66M | |
| 64.06M | 47.03M | 6.90M | 3.37M | 2.63M | |
| 64.06M | 47.03M | 6.90M | 3.37M | 2.63M |
